• Shopping cart is empty.

    The International Society for Aerosols in Medicine

    Detailed Program Sunday, May 26

    ISAM 2019 – Detailed Program

    General Overview Sunday, May 26 Monday, May 27 Tuesday, May 28 Wednesday, May 29

    Click on speaker name to see bio and abstract.

    Sunday – May 26, 2019

    08:15 – 08:30 Opening of the Conference
    08:30 – 10:00 SESSION 1 – New Devices and Emerging Therapies
    Miles Davis Hall

    Chair: Reinhard Vehring, University of Alberta


    8.30-8.55
    (I-01) Anthony J. Hickey, University of North Carolina and RTI International
    Global Needs in Respiratory Drug Delivery

    8.55-9.20
    (I-02) Nathalie Heuzé-Vourc’hInserm U1100 – Research Center for Respiratory Diseases
    Inhaled bacteriophages against respiratory infection 

     

    9.20-9.40
    (N-015) Leslie Yeo, Micro/Nanophysics Research Laboratory, RMIT University, Australia 
    Novel Portable Handheld Nebulization Platform for Pulmonary Delivery of Unprotected Plasmid DNA for Effective Influenza Vaccination 

    9.40-10.00
    (N-107) Philip J Kuehl, Lovelace Biomedical Research Institute, Albuquerque, New Mexico, USA 
    Nose to Brain Delivery – Evaluation of a Non-Human Primate Model with the Model Compound Sumatriptan


     

    10:00 – 10:30 Coffee Break / Exhibition Visit
    Level A3 - Ground Floor
    10:30 – 12:00 SESSION 2 – Bridging the gap between in vitro, in silico and clinical data: Obstacles and Success
    Miles Davis Hall

    Chair: David Cipolla, Insmed Incorporated, Jolyon Mitchell, Jolyon Mitchell Inhaler Consulting Services Inc.



    10.30-10.55
    (I-03) Dennis Sandell, S5 Consulting 
    Pharmacokinetic comparison of a budesonide/formoterol DPI and Symbicort® Turbuhale® using a multi-batch approach

    10.55-11.10
    (R-017) Mårten Svensson, Emmace Consulting AB, Medicon Village, Lund, Sweden
    Better prediction of clinical outcome through realistic in vitro testing of OINDPs

    11.10-11.25
    (A-101) Taciano Rocha, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil
    Development of a realistic 3D printed human oropharynx for in vitro testing

    11.25-11.40
    (A-001) J Sznitman, Department of Biomedical Engineering, Technion – Israel Institute of Technology, Haifa, Israel
    Advanced in vitro lung-on-chip platforms for inhalation aerosol screening assays

    11.40-11.55
    (R-014) Jolyon Mitchell, Jolyon Mitchell Inhaler Consulting Services Inc., London, Canada; Mark W. Nagel from Trudell Medical International (TMI)
    Should More Clinically Relevant APSD Methods be introduced into the Pharmacopeial Compendia




    12:00 – 14:00 Editorial Lunch / Lunch in Exhibition Area
    14:00 – 15:30 Best Oral Presentation
    Miles Davis Hall

    Chair:  Jessica Oakes

    14.00-14.15
    (E-026) Hana Barosova, Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
    Repeated long-term exposures of multi-walled carbon nanotubes to the 3D human lung model EpiAlveolarTM to predict the onset of fibrosis

    14.15-14.30
    (A-044) Huck B., Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) and Helmholtz Centre for Infection Research (HZI), Department of Drug Delivery, Saarbruecken, Germany
    Isolation of surfactant from human tracheobronchial mucus to study particle-interaction at the air-liquid interface

    14.30-14.45
    (N-020) Nivedita Shetty, Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, IN, USA
    Improving Physical and Aerosol Stability of Spray Dried High-dose Dry Powder Inhaler formulations

    14.45-15.00
    (O-112) Zainab Farzal, Department of Otolaryngology/Head & Neck Surgery, University of North Carolina at Chapel Hill, North Carolina, USA
    Comparative Analysis of Nebulizer and “Line of Sight” Spray Drug Delivery to Chronic Rhinosinusitis Target Sites

    15.00-15.15
    (P-049) T. Wilms, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
    Development of a long-acting version of dornase alfa for the treatment of cystic fibrosis

    15.15-15.30
    (N-084) Yara-Maria Proust
    1 AlveoliX AG, Bern, Switzerland
    2 ARTORG Center for Biomedical Engineering Research, Organs-on-Chip Technologies, University of Bern, Bern, Switzerland.
    3 Laboratory of L'Ecole polytechnique fédérale de Lausanne, Lausanne, Switzerland
    Nanoparticle exposure on a breathing alveolus-on-chip



    15:30 – 16:00 Coffee Break / Posters
    Level A4 (Upstairs)
    16:00 – 17:00 Networking Groups
    Pediatrics & CF Regulatory & Standardization Working Groups

    Level A4 - Upstairs


    17:00 – 18:00 Poster Session with Refreshments
    Level A4 (Upstairs)

    ISAM 2019 Congress

    The 22nd Congress of the International Society for Aerosols in Medicine
    May 25-29, 2019
    Montreux, Switzerland

    Enjoy the ISAM Congress 2019 inspired by the lovely scenery of Lake Geneva combined with the intellectual rigor of scientists coming from all over the world.

    Register Now